Legend Biotech Ownership | Who Owns Legend Biotech?
Legend Biotech Ownership Summary
Legend Biotech is owned by 49.97% institutional investors, 1.31% insiders, and 48.72% retail investors. Fmr is the largest institutional shareholder, holding 9.68% of LEGN shares. Fidelity Select Health Care is the top mutual fund, with 1.41% of its assets in Legend Biotech shares.
LEGN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Legend Biotech | 49.97% | 1.31% | 48.72% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 17.62M | 9.68% | $780.46M |
Price t rowe associates inc /md/ | 11.49M | 6.31% | $508.86M |
Ra capital management | 7.51M | 4.12% | $332.48M |
Hhlr advisors | 6.64M | 3.65% | $293.93M |
Blackrock | 5.72M | 3.14% | $253.40M |
Westfield capital management co lp | 4.77M | 2.62% | $211.36M |
Wellington management group llp | 2.81M | 1.54% | $124.43M |
Janus henderson group | 2.36M | 1.30% | $104.47M |
Capital investors | 2.16M | 1.19% | $95.79M |
Massachusetts financial services co /ma/ | 1.96M | 1.08% | $86.84M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Matthews capital management | 1.02M | 9.86% | $45.30M |
Johnson & johnson | 814.59K | 9.00% | $36.08M |
Superstring capital management lp | 154.66K | 8.64% | $6.85M |
Hhlr advisors | 6.64M | 7.25% | $293.93M |
Cutter capital management, lp | 343.13K | 4.59% | $15.20M |
Ra capital management | 7.51M | 4.40% | $332.48M |
Tri locum partners lp | 356.53K | 3.99% | $15.79M |
Braidwell lp | 1.67M | 2.32% | $73.95M |
E fund management (hong kong) | 58.43K | 1.59% | $2.59M |
Boxer capital | 600.00K | 1.40% | $26.57M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Westfield capital management co lp | 4.77M | 1.04% | 2.53M |
Fmr | 17.62M | 0.05% | 1.47M |
Hhlr advisors | 6.64M | 7.25% | 651.95K |
Ra capital management | 7.51M | 4.40% | 645.84K |
Ameriprise financial | 657.39K | 0.01% | 563.67K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Capital world investors | - | - | -2.39M |
Paradigm biocapital advisors lp | - | - | -1.20M |
Holocene advisors, lp | - | - | -761.63K |
Pfm health sciences, lp | - | - | -734.29K |
Manufacturers life insurance company, the | 86.41K | 0.00% | -466.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Balyasny asset management | 451.96K | 0.04% | 451.96K | $20.02M |
Point72 asset management | 304.52K | 0.04% | 304.52K | $13.49M |
Superstring capital management lp | 154.66K | 8.64% | 154.66K | $6.85M |
Centerbook partners lp | 154.07K | 0.42% | 154.07K | $6.82M |
Mirae asset global etfs | 86.34K | 0.01% | 86.34K | $3.82M |
Sold Out
Holder | Change |
---|---|
Vermillion & white wealth management group | -25.00 |
Peak6 investments | -200.00 |
Lazard asset management | -380.00 |
American group | -900.00 |
Am squared | -1.60K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 217 | 14.81% | 91,247,449 | -0.49% | 49 | 1.98% | 116 | 5.45% | 63 | 31.25% |
Jun 30, 2024 | 186 | -11.85% | 91,687,379 | 5.90% | 50 | 2.08% | 107 | -5.31% | 48 | -23.81% |
Mar 31, 2024 | 211 | -7.05% | 86,578,276 | 0.79% | 49 | 8.08% | 113 | -13.08% | 63 | 6.78% |
Dec 31, 2023 | 227 | 5.09% | 85,900,395 | -0.06% | 24 | 1.03% | 130 | 36.84% | 59 | -16.90% |
Sep 30, 2023 | 216 | 6.93% | 85,954,399 | 1.67% | 48 | 1.87% | 95 | -12.04% | 71 | 7.58% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Select Health Care | 2.60M | 1.41% | 100.00K |
Fidelity Growth Compy Commingled Pl S | 2.45M | 1.33% | 15.11K |
Fidelity Growth Compy Commingled Pl O | 2.43M | 1.32% | - |
T. Rowe Price Growth Stock | 2.32M | 1.26% | - |
T. Rowe Price US Growth Stock Composite | 2.32M | 1.26% | -77.22K |
Invesco Developing Markets A | 2.04M | 1.10% | 360.17K |
Invesco Emerging Markets Equity | 2.04M | 1.10% | 2.04M |
Fidelity Growth Company Fund | 1.76M | 0.96% | -3.75K |
Fidelity Advisor Health Care I | 1.60M | 0.87% | 40.00K |
MFS Mid Cap Growth Equity | 1.56M | 0.85% | 241.52K |
LEGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools